(Q54062279)

24 May 2018

title

Gabapentin as add-on therapy in focal epilepsy: a computerized EEG study. (English)

1 reference

24 May 2018

0 references

1 reference

1

1 reference

24 May 2018

Andrea Romigi

4

1 reference

24 May 2018

Fabio Placidi

5

1 reference

24 May 2018

author name string

F Spanedda

2

1 reference

24 May 2018

M A Bassetti

3

1 reference

24 May 2018

M G Marciani

6

1 reference

24 May 2018

publication date

1 February 2000

1 reference

24 May 2018

published in

Clinical Neurophysiology

1 reference

24 May 2018

volume

111

1 reference

24 May 2018

issue

2

1 reference

24 May 2018

page(s)

311-317

1 reference

24 May 2018

Gabapentin monotherapy: I. An 8-day, double-blind, dose-controlled, multicenter study in hospitalized patients with refractory complex partial or secondarily generalized seizures. The US Gabapentin Study Group 88/89

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS1388-2457%2899%2900240-0

7 January 2021

Conversion to high dose gabapentin monotherapy in patients with medically refractory partial epilepsy

1 reference

https://api.crossref.org/works/10.1016%2FS1388-2457%2899%2900240-0

7 January 2021

Gabapentin as an antiepileptic drug in man

1 reference

https://api.crossref.org/works/10.1016%2FS1388-2457%2899%2900240-0

7 January 2021

Transformations towards the normal distribution of broad band spectral parameters of the EEG

1 reference

https://api.crossref.org/works/10.1016%2FS1388-2457%2899%2900240-0

7 January 2021

Relationships between triggered seizures, spontaneous seizures, and interictal spiking in the kindling model of epilepsy

1 reference

https://api.crossref.org/works/10.1016%2FS1388-2457%2899%2900240-0

7 January 2021

Electroencephalographic spiking activity, drug levels, and seizure occurrence in epileptic patients.

1 reference

https://api.crossref.org/works/10.1016%2FS1388-2457%2899%2900240-0

7 January 2021

Efficacy and tolerance of long-term, high-dose gabapentin: additional observations

1 reference

https://api.crossref.org/works/10.1016%2FS1388-2457%2899%2900240-0

7 January 2021

Localization of [3H]gabapentin to a novel site in rat brain: autoradiographic studies

1 reference

https://api.crossref.org/works/10.1016%2FS1388-2457%2899%2900240-0

7 January 2021

Gabapentin and cognition: a double blind, dose ranging, placebo controlled study in refractory epilepsy

1 reference

https://api.crossref.org/works/10.1016%2FS1388-2457%2899%2900240-0

7 January 2021

Long-term treatment with gabapentin for partial epilepsy

1 reference

https://api.crossref.org/works/10.1016%2FS1388-2457%2899%2900240-0

7 January 2021

Double-blind study of Gabapentin in the treatment of partial seizures.

1 reference

https://api.crossref.org/works/10.1016%2FS1388-2457%2899%2900240-0

7 January 2021

Characterisation of [3H]gabapentin binding to a novel site in rat brain: homogenate binding studies

1 reference

https://api.crossref.org/works/10.1016%2FS1388-2457%2899%2900240-0

7 January 2021

Gabapentin as add-on therapy in refractory partial epilepsy: a double-blind, placebo-controlled, parallel-group study. The US Gabapentin Study Group No. 5

1 reference

https://api.crossref.org/works/10.1016%2FS1388-2457%2899%2900240-0

7 January 2021

The long-term safety and efficacy of gabapentin (Neurontin) as add-on therapy in drug-resistant partial epilepsy. The US Gabapentin Study Group

1 reference

https://api.crossref.org/works/10.1016%2FS1388-2457%2899%2900240-0

7 January 2021

10.1016/S1388-2457(99)00240-0

Identifiers

DOI

1 reference

24 May 2018

1 reference

24 May 2018